Description
- Delivers front-loaded bolus dosing during critical first 1/3 of each breath
- Provides drug deposition deep into the lungs
- High quality aerosol – 80% of particles in the respirable range (<5 microns)
- Improved patient outcomes translate into financial benefits
- Quick yet effective treatment – 50% shorter treatment times than AeroEclipse II
- 82% of treatments completed in less than 3 minutes
- 45º angle for maximizing patient comfort and treatment compliance
- Patient-friendly accessories provide flexible and improved respiratory treatment
- Mask, filter, and positive expiratory pressure (PEP) available
- Filter provides RT protection from exhaled medications
- Spans the full continuum of patient care: pediatrics through elderly